-
Patient Preferences in Targeted Pharmacotherapy for Cancers: A Systematic Review of Discrete Choice Experiments
Author: Jiang, Shan; Ren, Ru; Gu, Yuanyuan; Jeet, Varinder; Liu, Ping; Li, Shunping
Journal: PHARMACOECONOMICS. 2023; Vol. 41, Issue 1, pp. 43-57. DOI: 10.1007/s40273-022-01198-8
-
Whether and How Disutilities of Adverse Events were Used in the Economic Evaluation of Drug Therapy for Cancer Treatment
Author: Lu, Yuqiong; Dai, Zhanjing; Chang, Feng; Wang, Li; He, Jiafang; Shi, Penghua; Zhang, Haitao; Lu, Yun
Journal: PHARMACOECONOMICS. 2023; Vol. 41, Issue 3, pp. 295-306. DOI: 10.1007/s40273-022-01232-9
-
Identifying Attributes for a Value Assessment Framework in China: A Qualitative Study
Author: Zhang, Mengmeng; Bao, Yun; Yang, Yi; Kimber, Melissa; Levine, Mitchell; Xie, Feng
Journal: PHARMACOECONOMICS. 2023; Vol. 41, Issue 4, pp. 439-455. DOI: 10.1007/s40273-022-01235-6
-
Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled Trial
Author: Fuxiao Li, Xiang Li, Chuanhai Guo, Ruiping Xu, Fenglei Li, Yaqi Pan, Mengfei Liu, Zhen Liu, Chao Shi, Hui Wang, Minmin Wang, Hongrui Tian, Fangfang Liu, Ying Liu, Jingjing Li, Hong Cai, Li Yang, Zhonghu He, Yang Ke
Journal: PHARMACOECONOMICS, 2019, Vol., , DOI:10.1007/s40273-019-00766-9
-
Time Trends and Determinants of Pharmaceutical Expenditure in China (1990–2009)
Author: Lizheng Shi, Heidi Y. Yang, Gang Cheng, Qingyue Meng
Journal: PHARMACOECONOMICS, 2013, Vol.32, 257-264, DOI:10.1007/s40273-013-0072-3
-
Impacts of Health Insurance Benefit Design on Percutaneous Coronary Intervention Use and Inpatient Costs among Patients with Acute Myocardial Infarction in Shanghai, China
Author: Suwei Yuan, Yan Liu, Na Li, Yunting Zhang, Zhe Zhang, Jingjing Tao, Lizheng Shi, Hude Quan, Mingshan Lu, Jin Ma
Journal: PHARMACOECONOMICS, 2013, Vol.32, 265-275, DOI:10.1007/s40273-013-0079-9
-
Pharmaceutical Pricing: An Empirical Study of Market Competition in Chinese Hospitals
Author: Jing Wu, Judy Xu, Gordon Liu, Jiuhong Wu
Journal: PHARMACOECONOMICS, 2013, Vol.32, 293-303, DOI:10.1007/s40273-013-0099-5
-
Cost–Utility Analysis of the Newly Recommended Adjuvant Chemotherapy for Resectable Gastric Cancer Patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer
Author: Tan Chongqing, Peng Liubao, Zeng Xiaohui, Li Jianhe, Wan Xiaomin, Chen Gannong, Wang Siying, Ouyang Lihui, Zhao Ziying
Journal: PHARMACOECONOMICS, 2013, Vol.32, 235-243, DOI:10.1007/s40273-013-0065-2
